US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Global X HealthTech ETF

29.45

-0.1685-0.57%

Post-market: 29.610.1650+0.56%16:15 EDT

Volume:2K

Turnover:49.29K

Market Cap:30.91M

PE:- -

High:29.67

Open:29.61

Low:29.45

Close:29.61

52wk High:33.59

52wk Low:23.00

Shares:1.05M

Float Shares:1.05M

Volume Ratio:0.46

T/O Rate:0.16%

Dividend:0.07

Dividend Rate:0.24%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

IQVIA Partners with Medera to Advance Cardiac Gene Therapy Development

DexCom Director Mark G. Foletta Disposes of 4,000 Common Shares Worth $330,640

Gartner Inc. Stock Climbs 22.6%, Outperforms Peers

IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery

THOMSON REUTERS

Analysts’ Top Healthcare Picks: Dexcom (DXCM), AxoGen (AXGN)

Oscar Health Inc Expected to Post Earnings of 39 Cents a Share - Earnings Preview

Tempus AI announces study results of PRISM2

Tempus AI Inc : Btig Cuts Target Price to $70 from $80

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Rocket Pharmaceuticals (RCKT)

Tempus AI price target lowered to $56 from $64 at H.C. Wainwright

THRIVE Trial Puts IQVIA in Focus as Renal Denervation Race Heats Up

Tempus AI is Maintained at Hold by Stifel

Tempus AI–Personalis Deal: Integration Risks, Rising Costs, and Regulatory Scrutiny Could Undermine Synergy Gains

DexCom (DXCM) Stock Surges On Margin Strength And Raised Outlook

Simply Wall St.

Top IQVIA Insiders Quietly Unload Millions in Company Stock

IQVIA CEO Ari Bousbib Disposes of Common Shares Worth $26.23 Million

DexCom (DXCM) Stock May Be Below Fair Value Following Raised Guidance

Simply Wall St.

Stryker Corp Stock (SYK) Moved Down by 6.58% on Jul 31: What Investors Need To Know

Analysts Offer Insights on Healthcare Companies: AptarGroup (ATR), Mettler-Toledo (MTD) and Dexcom (DXCM)

DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/HEAL/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HEAL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HEAL\",,,,,undefined,":{"symbol":"HEAL","market":"US","secType":"STK","nameCN":"Global X HealthTech ETF","latestPrice":29.445,"timestamp":1788292800000,"preClose":29.6135,"halted":0,"volume":1664,"hourTrading":{"tag":"盘后","latestPrice":29.61,"preClose":29.445,"latestTime":"16:15 EDT","volume":16,"amount":470.735,"timestamp":1788293700321,"change":0.165,"changeRate":0.005604,"amplitude":0},"delay":0,"changeRate":-0.005689972478768066,"floatShares":1049843,"shares":1049843,"eps":0,"marketStatus":"Not Yet Opened","change":-0.1685,"latestTime":"09-01 16:00:00 EDT","open":29.61,"high":29.665,"low":29.445,"amount":49289,"amplitude":0.007429,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788336000000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":29.6135,"sharesOutstanding":1329868,"nav":29.74,"aum":31219751.28,"dividendRate":0.002421,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":29.61,"preClose":29.445,"latestTime":"16:15 EDT","volume":16,"amount":470.735,"timestamp":1788293700321,"change":0.165,"changeRate":0.005604,"amplitude":0},"volumeRatio":0.460304,"impliedVol":0.0888,"impliedVolPercentile":0.3984},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HEAL\",,,,,undefined,":{"symbol":"HEAL","floatShares":1049843,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.460304,"shares":1049843,"dividePrice":0.0713,"high":29.665,"amplitude":0.007429,"preClose":29.6135,"low":29.445,"week52Low":23,"pbRate":"--","week52High":33.59,"institutionHeld":0,"latestPrice":29.445,"eps":0,"divideRate":0.002421,"volume":1664,"delay":0,"ttmEps":0,"open":29.61,"prevYearClose":29.215,"prevWeekClose":29.715,"prevMonthClose":29.6135,"prevQuarterClose":27.59,"fiveDayClose":29.925,"twentyDayClose":28.05,"sixtyDayClose":25.22},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HEAL\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"HEAL","amount":0.071843,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Global X HealthTech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-07","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-07"},{"market":"US","date":"2025-09-02","symbol":"HEAL","defaultRemindTime":1756819800000,"type":"split","dateTimestamp":1756785600000,"forFactor":3,"toFactor":1,"ratio":3},{"date":"2025-06-27","symbol":"HEAL","amount":0.00815,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-27","defaultRemindTime":1751031000000,"name":"Global X HealthTech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-06-27","currency":"USD","dateTimestamp":1750996800000,"payDate":"2025-07-07"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HEAL\",market:\"US\",,,undefined,":[{"executeDate":"2025-06-27","recordDate":"2025-06-27","paymentDate":"2025-07-07","value":0.00815,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-07","value":0.071843,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HEAL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HEAL\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657627535","title":"IQVIA Partners with Medera to Advance Cardiac Gene Therapy Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2657627535","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657627535?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:59","pubTimestamp":1785877160,"startTime":"0","endTime":"0","summary":"IQVIA partners with Medera to advance cardiac gene therapy developmentIQVIA entered a strategic collaboration with Medera to speed development of cardiac gene therapies, using IQVIA’s global clinical ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL6HgJYk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0980610538.SGD","EKG","LU0130103400.USD","LU1791710582.SGD","LU1989764748.USD","BK4530","LU0130518102.USD","LU1791710400.SGD","LU0477156953.USD","LU0648000940.SGD","LU0198837287.USD","BK4588","BK4121","LU0882574055.USD","IQV","LU0130102774.USD","LU0130517989.USD","LU1201861165.SGD","LU0528227936.USD","LU0648001328.SGD","HEAL","BK4585","LU1261432733.SGD","LU1989764664.SGD","LU1201861249.SGD","LU0477156797.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657896562","title":"DexCom Director Mark G. Foletta Disposes of 4,000 Common Shares Worth $330,640","url":"https://stock-news.laohu8.com/highlight/detail?id=2657896562","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657896562?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:39","pubTimestamp":1785875991,"startTime":"0","endTime":"0","summary":"DexCom director Mark G. Foletta disposes of 4,000 common shares worth $330,640DexCom director Mark G. Foletta reported sales of 4,000 common shares at USD 80 to USD 85.32 per share.The transactions oc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL5Fy07p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"DexCom Director Mark G. Foletta Disposes of 4,000 Common Shares Worth $330,640","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4548","LU0266013472.USD","GB00BDT5M118.USD","LU2433249047.HKD","BK4504","LU2210149790.SGD","BK4082","LU1323610961.USD","LU0354030438.USD","EKG","BK4551","LU2211815571.USD","DXCM","LU0354030511.USD","LU2210150020.SGD","IE00BMPRXN33.USD","LU2125909593.SGD","BK4534","HEAL","IE00BMPRXR70.SGD","LU2125909247.SGD","BK4588","LU1923622614.USD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657564714","title":"Gartner Inc. Stock Climbs 22.6%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2657564714","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657564714?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:33","pubTimestamp":1785875580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Gartner Inc. rocketed 22.6% to $185.79 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.8% to 7,736.52 and the Dow Jones Industrial Average rising 1.7% to 54,085.88.This was the stock's second consecutive day of gains.Gartner Inc. closed 44.9% short of its 52-week high of $337.29, which the company achieved on August 4th.The stock outperformed some of its peers, as Trade Desk Inc. Cl A rose 5.7% to $19.34, IQVIA Holdings Inc. fell 2.2% to $228.20, and Omnicom Group Inc. rose 3.20% to $81.81.Trading volume totaled 3.7 million, compared to the 50-day average of 1.5 million.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EKG","LU1548497426.USD","LU0648000940.SGD","BK4134","LU1989764748.USD","LU2362541513.USD","LU0980610538.SGD","HEAL","LU1509826696.USD","BK4585","LU0107464264.USD","TTDU","IQV","LU2362541273.HKD","LU1599440770.SGD","LU2517655028.SGD","BK4023","BK4588","LU1481011671.HKD","LU0648001328.SGD","LU0882574055.USD","IE00BFXG1179.USD","LU1481011911.USD","LU2517655291.USD","BK4530","LU2362540622.SGD","LU0477156797.USD","BK4009","LU1989764664.SGD","LU1720051017.SGD","LU1720051108.HKD","BK4528","IT","LU0321505439.SGD","LU1201861165.SGD","LU0130103400.USD","LU0130518102.USD","LU0528227936.USD","LU0742537680.HKD","TTD","LU2357305700.SGD","BK4548","LU0198837287.USD","OMC","LU1201861249.SGD","LU0154245756.USD","LU0321505868.SGD","LU0477156953.USD","RSPC","LU0154245673.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657956131","title":"IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2657956131","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657956131?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:15","pubTimestamp":1785874500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nTUA8B2DFK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0198837287.USD","LU0130103400.USD","LU0130518102.USD","LU0130102774.USD","LU0980610538.SGD","LU0648001328.SGD","IQV","LU1989764748.USD","LU0882574055.USD","BK4530","BK4588","LU1791710400.SGD","LU1791710582.SGD","LU0130517989.USD","LU1261432733.SGD","BK4585","LU1989764664.SGD","EKG","LU0528227936.USD","LU0477156797.USD","BK4121","LU1201861249.SGD","HEAL","LU0477156953.USD","LU1201861165.SGD","LU0648000940.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656552807","title":"Analysts’ Top Healthcare Picks: Dexcom (DXCM), AxoGen (AXGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656552807","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656552807?lang=en_us&edition=fundamental","pubTime":"2026-08-04 22:20","pubTimestamp":1785853224,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Dexcom (DXCM), AxoGen (AXGN) and Axsome Therapeutics...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-dexcom-dxcm-axogen-axgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-dexcom-dxcm-axogen-axgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LU0354030511.USD","LU2125909593.SGD","BK4504","DXCM","LU2433249047.HKD","AXGN","IE00BMPRXN33.USD","LU0128526141.USD","BK4588","LU2095319765.USD","LU2210150020.SGD","LABU","XLV","BK4082","LU0029874061.USD","LU2125909247.SGD","BK4534","LU1323610961.USD","LU1923622614.USD","BK4585","XBI","LU0354030438.USD","BK4137","LU2210149790.SGD","EKG","HEAL","LU0266013472.USD","BK4581","LU2211815571.USD","BK4548","IE00BMPRXR70.SGD","BK4551","GB00BDT5M118.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656559312","title":"Oscar Health Inc Expected to Post Earnings of 39 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2656559312","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656559312?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:55","pubTimestamp":1785848120,"startTime":"0","endTime":"0","summary":"Oscar Health Inc <OSCR.N> expected to post earnings of39cents a share - Earnings PreviewOscar Health IncOSCR.N,OSCR.Kis expected to  show a rise in quarterly revenue when it reports  results on August","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL8N4411LF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSCR","OSCG","BK4162","BK4551","HEAL","OSCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656556427","title":"Tempus AI announces study results of PRISM2","url":"https://stock-news.laohu8.com/highlight/detail?id=2656556427","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656556427?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:36","pubTimestamp":1785846992,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) announced study results demonstrating that PRISM2, a multimodal slide-level pathology foundation model developed in collaboration w...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-announces-study-results-of-prism2-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-announces-study-results-of-prism2-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861559042.SGD","BK4121","BK4613","ARKG","LU1861558580.USD","BK4611","TEM","TEMT","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656320584","title":"Tempus AI Inc : Btig Cuts Target Price to $70 from $80","url":"https://stock-news.laohu8.com/highlight/detail?id=2656320584","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656320584?lang=en_us&edition=fundamental","pubTime":"2026-08-04 12:47","pubTimestamp":1785818835,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN4410CE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4611","ARKG","LU1861558580.USD","LU1861559042.SGD","BK4121","BK4613","HEAL","TEM","TEMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656305691","title":"Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Rocket Pharmaceuticals (RCKT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656305691","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656305691?lang=en_us&edition=fundamental","pubTime":"2026-08-04 01:40","pubTimestamp":1785778806,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tempus AI, Inc. Class A (TEM) and Rocket Pharmaceuti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tempus-ai-inc-class-a-tem-and-rocket-pharmaceuticals-rckt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tempus-ai-inc-class-a-tem-and-rocket-pharmaceuticals-rckt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARKG","HEAL","TEM","RCKT","LU1861559042.SGD","LU1861558580.USD","BK4613","TEMT","BK4139","BK4121","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656630306","title":"Tempus AI price target lowered to $56 from $64 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2656630306","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656630306?lang=en_us&edition=fundamental","pubTime":"2026-08-04 01:15","pubTimestamp":1785777323,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Yi Chen lowered the firm’s price target on Tempus AI (TEM) to $56 from $64 and keeps a Buy rating on the shares. The compan...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-price-target-lowered-to-56-from-64-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-price-target-lowered-to-56-from-64-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4611","LU1861558580.USD","BK4121","LU1861559042.SGD","BK4613","HEAL","TEMT","ARKG","TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656303699","title":"THRIVE Trial Puts IQVIA in Focus as Renal Denervation Race Heats Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2656303699","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656303699?lang=en_us&edition=fundamental","pubTime":"2026-08-04 00:31","pubTimestamp":1785774684,"startTime":"0","endTime":"0","summary":"IQVIA Holdings ($IQV) announced an update on their ongoing clinical study. The THRIVE study, officially titled “A Pivotal, Prospective, Multicenter...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/thrive-trial-puts-iqvia-in-focus-as-renal-denervation-race-heats-up?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/thrive-trial-puts-iqvia-in-focus-as-renal-denervation-race-heats-up?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0528227936.USD","LU0477156797.USD","BK4530","LU0130103400.USD","LU0130518102.USD","HEAL","LU0882574055.USD","LU0648001328.SGD","EKG","LU0198837287.USD","LU1989764748.USD","LU0477156953.USD","BK4121","LU0130102774.USD","BK4585","LU0980610538.SGD","BK4588","IQV","LU1989764664.SGD","LU1201861249.SGD","LU0648000940.SGD","LU1201861165.SGD","LU1791710400.SGD","LU1261432733.SGD","LU0130517989.USD","LU1791710582.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656379387","title":"Tempus AI is Maintained at Hold by Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2656379387","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656379387?lang=en_us&edition=fundamental","pubTime":"2026-08-03 20:17","pubTimestamp":1785759420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TEM/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861558580.USD","ARKG","LU1861559042.SGD","TEMT","BK4611","TEM","BK4121","HEAL","BK4613"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656839079","title":"Tempus AI–Personalis Deal: Integration Risks, Rising Costs, and Regulatory Scrutiny Could Undermine Synergy Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2656839079","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656839079?lang=en_us&edition=fundamental","pubTime":"2026-08-01 14:01","pubTimestamp":1785564068,"startTime":"0","endTime":"0","summary":"Tempus AI, Inc. Class A (TEM) has disclosed a new risk, in the Corporate Activity and Growth category. The proposed acquisition of Personalis will ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tempus-ai-personalis-deal-integration-risks-rising-costs-and-regulatory-scrutiny-could-undermine-synergy-gains?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tempus-ai-personalis-deal-integration-risks-rising-costs-and-regulatory-scrutiny-could-undermine-synergy-gains?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TEM","TEMT","HEAL","BK4121","ARKG","LU1861558580.USD","BK4613","BK4611","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656390516","title":"DexCom (DXCM) Stock Surges On Margin Strength And Raised Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2656390516","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656390516?lang=en_us&edition=fundamental","pubTime":"2026-08-01 11:38","pubTimestamp":1785555522,"startTime":"0","endTime":"0","summary":"DexCom stock rose 12% to US$83.45 after earnings, a sharp move for a large medical device company that has already delivered strong multi month gains. The headline is simple: investors rewarded a clean beat on profitability, with Q2 net income of US$269.1 million and earnings of US$0.70 per share, alongside firm evidence that its continuous glucose monitoring franchise is scaling efficiently.\nShort term traders are reacting to the jump in profits and margins. Longer term holders are now...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-dxcm/dexcom/news/dexcom-dxcm-stock-surges-on-margin-strength-and-raised-outlo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-dxcm/dexcom/news/dexcom-dxcm-stock-surges-on-margin-strength-and-raised-outlo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BMPRXN33.USD","LU1323610961.USD","LU2433249047.HKD","EKG","GB00BDT5M118.USD","HEAL","BK4504","LU2210150020.SGD","BK4588","BK4585","LU0266013472.USD","LU0354030438.USD","LU0354030511.USD","LU2210149790.SGD","LU2211815571.USD","IE00BMPRXR70.SGD","LU2125909247.SGD","BK4534","BK4551","BK4548","LU2125909593.SGD","DXCM","LU2095319765.USD","BK4082","LU1923622614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656397713","title":"Top IQVIA Insiders Quietly Unload Millions in Company Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2656397713","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656397713?lang=en_us&edition=fundamental","pubTime":"2026-08-01 10:04","pubTimestamp":1785549893,"startTime":"0","endTime":"0","summary":"New insider activity at IQVIA Holdings ( ($IQV) ) has taken place on July 31, 2026. Recent insider activity at IQVIA Holdings shows several top exe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-iqvia-insiders-quietly-unload-millions-in-company-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-iqvia-insiders-quietly-unload-millions-in-company-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0198837287.USD","LU1791710400.SGD","LU0477156797.USD","LU0528227936.USD","EKG","LU1791710582.SGD","LU0130518102.USD","LU1989764664.SGD","LU0648000940.SGD","BK4585","LU1201861165.SGD","BK4530","LU0648001328.SGD","HEAL","LU0882574055.USD","LU0980610538.SGD","BK4121","LU1261432733.SGD","IQV","BK4588","LU0130517989.USD","LU0130102774.USD","LU0130103400.USD","LU1201861249.SGD","LU1989764748.USD","LU0477156953.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656391432","title":"IQVIA CEO Ari Bousbib Disposes of Common Shares Worth $26.23 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2656391432","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656391432?lang=en_us&edition=fundamental","pubTime":"2026-08-01 05:02","pubTimestamp":1785531768,"startTime":"0","endTime":"0","summary":"IQVIA CEO Ari Bousbib disposes of common shares worth $26.23 millionIQVIA director, CEO, chairman, president Ari Bousbib exercised 156,206 stock appreciation rights on July 29, 2026 at $78.21.He sold ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL7Rv9dn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"IQVIA CEO Ari Bousbib Disposes of Common Shares Worth $26.23 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4588","LU0477156953.USD","EKG","HEAL","BK4530","LU0648001328.SGD","LU0130103400.USD","LU1989764748.USD","IQV","LU0130102774.USD","LU1989764664.SGD","LU0528227936.USD","LU0648000940.SGD","LU0882574055.USD","LU0198837287.USD","LU0477156797.USD","LU1201861249.SGD","LU0130518102.USD","LU0980610538.SGD","LU1791710582.SGD","LU0130517989.USD","LU1201861165.SGD","LU1261432733.SGD","LU1791710400.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656373399","title":"DexCom (DXCM) Stock May Be Below Fair Value Following Raised Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2656373399","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656373399?lang=en_us&edition=fundamental","pubTime":"2026-08-01 02:23","pubTimestamp":1785522217,"startTime":"0","endTime":"0","summary":"DexCom stock has delivered a roughly 43.1% decline over the past five years, yet an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach currently points to a sizeable gap between the share price and that estimate. At the same time, the broader valuation checks send a more mixed message, so recent news around product approvals and digital health partnerships is now being weighed against what investors are paying for the stock.\n\nThe roughly 43.1% share price decline over...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-dxcm/dexcom/news/dexcom-dxcm-stock-may-be-below-fair-value-following-raised-g","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-dxcm/dexcom/news/dexcom-dxcm-stock-may-be-below-fair-value-following-raised-g","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4551","LU0266013472.USD","DCF","LU1923622614.USD","LU2211815571.USD","DXCM","BK4548","LU2433249047.HKD","SPHQ","LU1323610961.USD","LU0354030438.USD","BK4534","BK4585","GB00BDT5M118.USD","HEAL","IE00BMPRXR70.SGD","BK4082","LU0354030511.USD","BK4504","LU2125909247.SGD","LU2125909593.SGD","IE00BMPRXN33.USD","EKG","LU2210149790.SGD","LU2210150020.SGD","LU2095319765.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656934763","title":"Stryker Corp Stock (SYK) Moved Down by 6.58% on Jul 31: What Investors Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2656934763","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656934763?lang=en_us&edition=fundamental","pubTime":"2026-08-01 01:15","pubTimestamp":1785518128,"startTime":"0","endTime":"0","summary":"• Stryker's stock declined following an earnings miss and contraction in operating margins.\n• Management lowered forward-looking guidance due to inflationary pressures and cooling elective procedure demand.\n• Analysts reduced price targets as automated selling programs accelerated downward stock momentum.","market":"hk","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262067987-market-movers-syk-20260731","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","GNOM","GNMX","LU0128526141.USD","SYK","BK4585","LU2089984988.USD","IE00BMPRXN33.USD","LU0114720955.EUR","LU0266013472.USD","BK4534","BK4551","LU0823417737.USD","LU0950375773.USD","LU0882574055.USD","LU2506951958.HKD","GB00B4LPDJ14.GBP","ISBC","HEAL","GB00B4QBRK32.GBP","LU0432979614.USD","LU2125909247.SGD","LU2362541513.USD","BK4211","LU1791710582.SGD","ILMN","GB00BDT5M118.USD","EKG","IHI","LU0289739699.SGD","LU0058720904.USD","LU0354030511.USD","LU1323610961.USD","DXCM","LU2125909593.SGD","BK4548","LU2433249047.HKD","LU2362540622.SGD","LU0690374961.EUR","BK4082","BK4566","LU2210150020.SGD","LU2095319765.USD","BK4504","LU2404859741.USD","LU1791710400.SGD","LU0528227936.USD","BK4121","LU2506952097.USD","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656393157","title":"Analysts Offer Insights on Healthcare Companies: AptarGroup (ATR), Mettler-Toledo (MTD) and Dexcom (DXCM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656393157","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656393157?lang=en_us&edition=fundamental","pubTime":"2026-08-01 01:10","pubTimestamp":1785517856,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AptarGroup (ATR), Mettler-Toledo (MTD) and Dexcom (D...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-aptargroup-atr-mettler-toledo-mtd-and-dexcom-dxcm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-aptargroup-atr-mettler-toledo-mtd-and-dexcom-dxcm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LABU","LU1093756325.SGD","LU2210149790.SGD","BK4504","LU2413666699.HKD","BK4126","GB00BDT5M118.USD","IE00BMPRXN33.USD","IE00BYQQ9H92.USD","XBI","BK4534","BK4581","BK4588","LU1093756168.USD","LU1323610961.USD","LU0029874061.USD","LU2125909247.SGD","LU0128526141.USD","LU2095319765.USD","BK4551","BK4121","BK4585","LU2413666426.HKD","IE00B5TLWC47.USD","LU1721428933.USD","DXCM","EKG","LU0354030438.USD","LU2211815571.USD","BK4548","MTD","XLV","LU2210150020.SGD","ATR","LU2211817866.USD","LU0354030511.USD","IE00BFXG0V08.USD","LU0347712357.USD","BK4533","IE00BMPRXR70.SGD","BK4137","LU0266013472.USD","LU2125909593.SGD","LU1923622614.USD","HEAL","LU2433249047.HKD","BK4082","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656398687","title":"DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2656398687","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656398687?lang=en_us&edition=fundamental","pubTime":"2026-07-31 23:55","pubTimestamp":1785513309,"startTime":"0","endTime":"0","summary":"DexCom's  upcoming national coverage determination for its continuous glucose monitoring system and strong demand momentum could support an even more positive H2 outlook, RBC Capital Markets said in a note Friday.The company's G7 15-day CGM is now accessible to adult G7 customers in the US following the availability of Tandem's  Tandem Mobi automated insulin pump, and management is on track to convert nearly 50% of its US installed base by year-end, according to the note.The investment firm said the combination of expanded G7 access, product cycle momentum, and improving customer satisfaction positions the company for potential US upside in H2.International markets remain crucial to DexCom's growth story, with global new starts matching prior-quarter records and G7 15-day cleared in Canada, the firm said, adding that it sees the 15-day rollout as a key driver for consistent double-digit international growth.RBC Capital Markets kept an outperform rating on DexCom and raised its price ta","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0029864427.USD","BK4207","LU2211815571.USD","TNDM","BK4585","LU0128525929.USD","LU2210149790.SGD","LU1923622614.USD","NHLD","DXCM","BK4082","LU0354030511.USD","LU2433249047.HKD","BK4534","LU0310800379.SGD","IE00BMPRXR70.SGD","LU2125909247.SGD","LU0354030438.USD","GSIB","LU1323610961.USD","HEAL","IE00BMPRXN33.USD","EKG","LU0266013472.USD","BK4551","LU2210150020.SGD","BK4504","LU2095319765.USD","LU2125909593.SGD","BK4588","BK4548","LU1267930573.SGD","LU0708994859.HKD","GB00BDT5M118.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}